157 related articles for article (PubMed ID: 7488187)
1. Formation of malondialdehyde-modified 2'-deoxyguanosinyl adduct from metabolism of chloral hydrate by mouse liver microsomes.
Ni YC; Kadlubar FF; Fu PP
Biochem Biophys Res Commun; 1995 Nov; 216(3):1110-7. PubMed ID: 7488187
[TBL] [Abstract][Full Text] [Related]
2. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
3. Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism.
Ni YC; Wong TY; Lloyd RV; Heinze TM; Shelton S; Casciano D; Kadlubar FF; Fu PP
Drug Metab Dispos; 1996 Jan; 24(1):81-90. PubMed ID: 8825194
[TBL] [Abstract][Full Text] [Related]
4. Tumorigenicity of chloral hydrate, trichloroacetic acid, trichloroethanol, malondialdehyde, 4-hydroxy-2-nonenal, crotonaldehyde, and acrolein in the B6C3F(1) neonatal mouse.
Von Tungeln LS; Yi P; Bucci TJ; Samokyszyn VM; Chou MW; Kadlubar FF; Fu PP
Cancer Lett; 2002 Nov; 185(1):13-9. PubMed ID: 12142074
[TBL] [Abstract][Full Text] [Related]
5. Species- and sex-related differences in metabolism of trichloroethylene to yield chloral and trichloroethanol in mouse, rat, and human liver microsomes.
Elfarra AA; Krause RJ; Last AR; Lash LH; Parker JC
Drug Metab Dispos; 1998 Aug; 26(8):779-85. PubMed ID: 9698293
[TBL] [Abstract][Full Text] [Related]
6. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.
Abbas R; Fisher JW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):15-30. PubMed ID: 9356303
[TBL] [Abstract][Full Text] [Related]
7. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062
[TBL] [Abstract][Full Text] [Related]
8. An improved 32P-postlabeling/high-performance liquid chromatography method for the analysis of the malondialdehye-derived 1, N2-propanodeoxyguanosine DNA adduct in animal and human tissues.
Yi P; Sun X; Doerge DR; Fu PP
Chem Res Toxicol; 1998 Sep; 11(9):1032-41. PubMed ID: 9760277
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of chloral hydrate and its metabolites in male human volunteers.
Merdink JL; Robison LM; Stevens DK; Hu M; Parker JC; Bull RJ
Toxicology; 2008 Mar; 245(1-2):130-40. PubMed ID: 18243465
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice.
Abbas RR; Seckel CS; Kidney JK; Fisher JW
Drug Metab Dispos; 1996 Dec; 24(12):1340-6. PubMed ID: 8971140
[TBL] [Abstract][Full Text] [Related]
11. Hepatic metabolism of chloral hydrate to free radical(s) and induction of lipid peroxidation.
Ni YC; Wong TY; Kadlubar FF; Fu PP
Biochem Biophys Res Commun; 1994 Oct; 204(2):937-43. PubMed ID: 7980564
[TBL] [Abstract][Full Text] [Related]
12. Chloral hydrate sedation in neonates and infants--clinical and pharmacologic considerations.
Reimche LD; Sankaran K; Hindmarsh KW; Kasian GF; Gorecki DK; Tan L
Dev Pharmacol Ther; 1989; 12(2):57-64. PubMed ID: 2714158
[TBL] [Abstract][Full Text] [Related]
13. The effect of chloral hydrate and its metabolites, trichloroethanol and trichloroacetic acid, on bilirubin-albumin binding.
Onks DL; Robertson AF; Brodersen R
Pharmacol Toxicol; 1992 Sep; 71(3 Pt 1):196-7. PubMed ID: 1438041
[TBL] [Abstract][Full Text] [Related]
14. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
[TBL] [Abstract][Full Text] [Related]
16. Extrahepatic metabolism of chloral hydrate, trichloroethanol and trichloroacetic acid in dogs.
Hobara T; Kobayashi H; Kawamoto T; Iwamoto S; Sakai T
Pharmacol Toxicol; 1987 Jul; 61(1):58-62. PubMed ID: 3628182
[TBL] [Abstract][Full Text] [Related]
17. Alteration of chloral hydrate metabolism in rats with carbon tetrachloride-induced liver damage.
Kawamoto T; Hobara T; Kobayashi H; Iwamoto S; Sakai T; Ogino K
Toxicol Lett; 1987 Aug; 37(3):263-8. PubMed ID: 3617101
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
Greenberg MS; Burton GA; Fisher JW
Toxicol Appl Pharmacol; 1999 Feb; 154(3):264-78. PubMed ID: 9931286
[TBL] [Abstract][Full Text] [Related]
19. A species comparison of chloral hydrate metabolism in blood and liver.
Lipscomb JC; Mahle DA; Brashear WT; Garrett CM
Biochem Biophys Res Commun; 1996 Oct; 227(2):340-50. PubMed ID: 8878519
[TBL] [Abstract][Full Text] [Related]
20. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
Fisher JW; Mahle D; Abbas R
Toxicol Appl Pharmacol; 1998 Oct; 152(2):339-59. PubMed ID: 9853003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]